DK0779896T3 - Ny fremgangsmåde til fremstilling af biologisk aktivt protein (TGF) - Google Patents

Ny fremgangsmåde til fremstilling af biologisk aktivt protein (TGF)

Info

Publication number
DK0779896T3
DK0779896T3 DK95926858T DK95926858T DK0779896T3 DK 0779896 T3 DK0779896 T3 DK 0779896T3 DK 95926858 T DK95926858 T DK 95926858T DK 95926858 T DK95926858 T DK 95926858T DK 0779896 T3 DK0779896 T3 DK 0779896T3
Authority
DK
Denmark
Prior art keywords
tgf
biologically active
new method
active protein
producing biologically
Prior art date
Application number
DK95926858T
Other languages
English (en)
Inventor
Nico Cerletti
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0779896T3 publication Critical patent/DK0779896T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95926858T 1994-07-25 1995-07-12 Ny fremgangsmåde til fremstilling af biologisk aktivt protein (TGF) DK0779896T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94810439 1994-07-25
PCT/EP1995/002719 WO1996003433A1 (en) 1994-07-25 1995-07-12 New process for the production of biologically active protein

Publications (1)

Publication Number Publication Date
DK0779896T3 true DK0779896T3 (da) 2002-02-18

Family

ID=8218293

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95926858T DK0779896T3 (da) 1994-07-25 1995-07-12 Ny fremgangsmåde til fremstilling af biologisk aktivt protein (TGF)

Country Status (19)

Country Link
US (1) US7057016B2 (da)
EP (1) EP0779896B1 (da)
JP (2) JPH11505404A (da)
KR (1) KR100394532B1 (da)
AT (1) ATE207934T1 (da)
AU (1) AU699879B2 (da)
CA (1) CA2194578A1 (da)
DE (1) DE69523611T2 (da)
DK (1) DK0779896T3 (da)
ES (1) ES2166402T3 (da)
FI (1) FI118385B (da)
HU (1) HU222829B1 (da)
IL (1) IL114702A (da)
NO (1) NO317730B1 (da)
NZ (1) NZ290374A (da)
PT (1) PT779896E (da)
TW (1) TW517059B (da)
WO (1) WO1996003433A1 (da)
ZA (1) ZA956139B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4019432B2 (ja) * 1995-12-21 2007-12-12 味の素株式会社 ヒトアクチビンａのリフォールディング方法
DE10026713A1 (de) * 2000-05-30 2001-12-06 Walter Sebald Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta
US20030134292A1 (en) * 2001-10-30 2003-07-17 Farchaus Joseph W. Thermostable DNA polymerases and methods of making same
FR2871061B1 (fr) * 2004-06-04 2007-08-10 Coletica Sa Principe actif capable d'induire la transformation du tgbf- latent inactif en tgfb actif
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
EP2324838A1 (en) 2005-09-12 2011-05-25 Abela Pharmaceuticals, Inc. Compositions Comprising Dimethyl Sulfoxide (DMSO)
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
JP5399072B2 (ja) 2005-09-12 2014-01-29 アベラ ファーマスーティカルズ インコーポレイテッド ジメチルスルホキシド（ｄｍｓｏ）若しくは関連化合物、又はそれに関連する臭気を除去するシステム
GB0604966D0 (en) * 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
AU2010313253B2 (en) 2009-10-30 2015-02-19 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
US10647777B2 (en) * 2014-05-28 2020-05-12 Genzyme Corporation Methods of controlling the formation of disulfide bonds in protein solutions
JP2016183118A (ja) * 2015-03-25 2016-10-20 東ソー株式会社 増殖因子前駆体のリフォールディング方法
WO2018122794A1 (en) 2016-12-30 2018-07-05 Biogend Therapeutics Co., Ltd. Recombinant polypeptides and nucleic acid molecules, compositions, and methods of making and uses thereof
KR20240082356A (ko) * 2021-10-11 2024-06-10 유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 조작된 tgf-베타 단량체 및 사용 방법
GB2616476A (en) * 2022-03-11 2023-09-13 Multus Biotechnology Ltd Recombinant transforming growth factor beta 3 in yeast

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0051985B2 (en) * 1980-11-07 1989-12-27 International Institute Of Cellular And Molecular Pathology (Icp) Immunoassay of proteins
US4620948A (en) 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
GR79124B (da) 1982-12-22 1984-10-02 Genentech Inc
EP0154434B1 (en) 1984-02-17 1993-01-27 Genentech, Inc. Human transforming growth factor and precursor or fragment thereof, cells, dna, vectors and methods for their production, compositions and products containing them, and related antibodies and diagnostic methods
US4572798A (en) 1984-12-06 1986-02-25 Cetus Corporation Method for promoting disulfide bond formation in recombinant proteins
US4731440A (en) 1985-02-22 1988-03-15 Monsanto Company Method of somatotropin solubilization using dimethylsulfone and naturation
IL78197A (en) 1985-03-22 1991-07-18 Genentech Inc Nucleic acid encoding tgf-beta and its uses
GB8508340D0 (en) 1985-03-29 1985-05-09 Creighton T E Production of protein
EP0208539A3 (en) 1985-07-11 1988-08-03 Repligen Corporation Folding disulfide-cross-linkable proteins
US5453363A (en) 1985-10-23 1995-09-26 Boehringer Mannheim Gmbh Process for the activation of t-PA or Ing after genetic expression in prokaryotes
JPH0759598B2 (ja) * 1986-02-14 1995-06-28 藤沢薬品工業株式会社 ヒトインスリン様成長因子▲ｉ▼の製造法
NZ222168A (en) 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
EP0268561A3 (en) 1986-11-17 1988-10-26 Sandoz Ag Production and use of a novel t-cell suppressor factor
FI100106B (fi) 1986-12-05 1997-09-30 Novartis Ag Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi
US4931548A (en) 1987-01-30 1990-06-05 Techne Corporation Heterodimer form of transforming growth factor-beta
IL86090A (en) 1987-04-16 1993-03-15 Cetus Oncology Corp Production of purified, biologically active, bacterially produced recombinant human csf-1
AU622860B2 (en) 1987-05-11 1992-04-30 Novartis Vaccines And Diagnostics, Inc. Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
US5162507A (en) 1987-05-11 1992-11-10 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
AU626524B2 (en) * 1987-05-29 1992-08-06 Bristol-Myers Squibb Company Cloning and expression of simian transforming growth factor- beta 1
US4985544A (en) 1987-08-04 1991-01-15 Kyowa Hakko Kogyo Co., Ltd. Process for renaturing fish growth hormone
US5061786A (en) * 1989-05-25 1991-10-29 Genentech, Inc. Biologically active polypeptides based on transforming growth factor-β
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
US5144006A (en) * 1991-06-13 1992-09-01 The Rockefeller University Oxidative folding of peptide and protein substrates using hydrocarbon sulfoxides
AU2738392A (en) * 1991-11-11 1993-05-13 Ciba-Geigy Ag Novel hybrid transforming growth factors
US5407810A (en) * 1993-08-20 1995-04-18 Genentech, Inc. Aqueous multiple-phase isolation of polypeptide
TW440566B (en) * 1994-07-25 2001-06-16 Novartis Ag Novel process for the production of biologically active dimeric protein

Also Published As

Publication number Publication date
IL114702A (en) 2005-03-20
NO970326D0 (no) 1997-01-24
JP2007082554A (ja) 2007-04-05
NZ290374A (en) 1998-07-28
TW517059B (en) 2003-01-11
DE69523611T2 (de) 2002-06-20
FI118385B (fi) 2007-10-31
FI970258A0 (fi) 1997-01-22
HU222829B1 (hu) 2003-11-28
JPH11505404A (ja) 1999-05-21
EP0779896A1 (en) 1997-06-25
NO317730B1 (no) 2004-12-13
AU3109695A (en) 1996-02-22
KR100394532B1 (ko) 2003-10-22
CA2194578A1 (en) 1996-02-08
ATE207934T1 (de) 2001-11-15
WO1996003433A1 (en) 1996-02-08
ES2166402T3 (es) 2002-04-16
JP4354980B2 (ja) 2009-10-28
EP0779896B1 (en) 2001-10-31
PT779896E (pt) 2002-03-28
US20020115834A1 (en) 2002-08-22
NO970326L (no) 1997-01-24
IL114702A0 (en) 1995-11-27
FI970258L (fi) 1997-01-22
AU699879B2 (en) 1998-12-17
DE69523611D1 (de) 2001-12-06
ZA956139B (en) 1996-03-07
HUT76667A (en) 1997-10-28
US7057016B2 (en) 2006-06-06

Similar Documents

Publication Publication Date Title
FI970258A0 (fi) Uusi menetelmä biologisesti aktiivisen proteiinin valmistamiseksi
DK0775159T3 (da) Ny fremgangsmåde til fremstilling af biologisk aktivt dimert protein
DE69739035D1 (de) Zusammensetzungen und Methoden zur Behandlung von Infektionen unter Verwendung von Indolicidinanalogen
DK0732340T3 (da) Ekspression af porcine reproduktions- og respirationssyndromviruspolypeptider i den samme celle
DK1165791T3 (da) Humant cytokin som zalpha-receptor-ligand og anvendelse deraf
AU5055593A (en) Antibodies specific for HIV
ATE68826T1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
NO895028L (no) Ny chimerisk transformerende vekstfaktor-beta.
DE59912242D1 (de) Verfahren zur herstellung von (s,s)-benzyl-2,8-diazabicyclo(4.3.0)nonan
DE59101580D1 (de) Trägergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine.
ATE113056T1 (de) Künstliche rezeptor-analoge.
DK0811058T3 (da) Fremgangsmåde til fremstilling af faktor IX ud fra biologiske kilder
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
ES2049021T3 (es) Metodo de recuperar la proteina epi purificada a partir de una solucion, especialmente una solucion de fermentacion.
MX9700657A (es) Nuevo proceso para la produccion de proteina biologicamente activa.
IL145403A0 (en) Fragments of virus protein 2 or 3 of the polyoma virus, use for transporting active ingredients
MX9700656A (es) Proceso novedoso para la produccion de proteina dimerica biologicamente activa.
FI970230L (fi) Menetelmä proteiinien, kuten yhdistelmä-DNA-hirudiinin tai -epidermaalisen kasvutekijän laskostamiseksi